Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Duloxetine hydrochloride
Pharmacor Pty Ltd
Duloxetine hydrochloride
Pharmacor Duloxetine CMI 1 PHARMACOR DULOXETINE (duloxetine hydrochloride) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PHARMACOR DULOXETINE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date shown on the final page. More recent information on this medicine may be available. Make sure you speak to your pharmacist or doctor to obtain the most up to date information on this medicine. All medicines have risks and benefits. Your doctor has weighed the risks of you taking PHARMACOR DULOXETINE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT PHARMACOR DULOXETINE IS USED FOR PHARMACOR DULOXETINE is used to treat major depressive disorder (depression), Diabetic Peripheral Neuropathic Pain (nerve pain caused by diabetes) and Generalised Anxiety Disorder (excessive worry) PHARMACOR DULOXETINE belongs to a group of medicines called Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs). SNRIs are believed to work by their action on serotonin and noradrenaline in the brain. Serotonin and noradrenaline are the chemical messengers responsible for controlling the psychological and painful physical symptoms of depression. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. YOUR DOCTOR MAY HAVE PRESCRIBED IT FOR ANOTHER REASON. This medicine is available only with a doctor's prescription. PHARMACOR DULOXETINE is not recommended for use in children and adolescents under the age of 18 years. BEFORE YOU TAKE PHARMACOR DULOXETINE _ _ _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE PHARMACOR DULOXETINE IF YOU HAVE AN ALLERGY TO: • any medicine containing duloxetine hydrochloride; • any of the ingredients listed at the end of this leaflet. Some of the Read the complete document
Pharmacor Duloxetine PI 1 PRODUCT INFORMATION PHARMACOR DULOXETINE (duloxetine hydrochloride, Pharmacor) NAME OF THE DRUG PHARMACOR DULOXETINE (duloxetine hydrochloride) PHARMACOR DULOXETINE is a selective serotonin and noradrenaline reuptake inhibitor (SNRI) for oral administration. It is chemically unrelated to tricyclics, alpha adrenergic receptor agonists or antimuscarinics. Its chemical designation is (+)-(_S_)-_N_- methyl - ɤ -(1-naphthalenyloxy)-2-thiophenepropanamine hydrochloride. The empirical formula is C 18 H 19 NOS•HCl, which corresponds to a molecular weight of 333.88. The CAS number for duloxetine hydrochloride is 136434-34-9. The structural formula is: DESCRIPTION Duloxetine hydrochloride is a white to off white powder, which is freely soluble in methanol, sparingly soluble in water and practically insoluble in hexane. Duloxetine is available as capsules for oral administration. Each capsule contains enteric- coated pellets of duloxetine hydrochloride equivalent to 30 mg or 60 mg of duloxetine that are designed to prevent degradation of the drug in the acidic environment of the stomach. Inactive ingredients include sugar spheres, hypromellose, hydroxypropylcellulose, crospovidone, talc-purified, triethyl citrate, titanium dioxide, hypromellose phthalate. The 30 mg capsules also contain gelatin, sodium lauryl sulphate, indigo carmine, TEK SW 0012 –white ink (ARTG No.13175) and TEK SW 9008 –black ink (ARTG No.2328). The 60 mg capsules also contain gelatin, sodium lauryl sulphate, iron oxide yellow, indigo carmine and TEK SW 0012 – white ink (ARTG No.13175). Pharmacor Duloxetine PI 2 PHARMACOLOGY PHARMACODYNAMICS Duloxetine is a selective serotonin and noradrenaline reuptake inhibitor (SNRI), and weakly inhibits dopamine uptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors. Although the mechanism of the antidepressant action of duloxetine in humans is unknown, it is believed to be related to its potentiation of serotonergic and noradrenerg Read the complete document